MX2023003933A - Derivados de acetamido-feniltetrazol y métodos para utilizar los mismos. - Google Patents
Derivados de acetamido-feniltetrazol y métodos para utilizar los mismos.Info
- Publication number
- MX2023003933A MX2023003933A MX2023003933A MX2023003933A MX2023003933A MX 2023003933 A MX2023003933 A MX 2023003933A MX 2023003933 A MX2023003933 A MX 2023003933A MX 2023003933 A MX2023003933 A MX 2023003933A MX 2023003933 A MX2023003933 A MX 2023003933A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- acetamido
- same
- phenyltetrazole
- phenyltetrazole derivatives
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- WXIDHXMFHAIRJC-UHFFFAOYSA-N n-[2-(2h-tetrazol-5-yl)phenyl]acetamide Chemical class CC(=O)NC1=CC=CC=C1C1=NNN=N1 WXIDHXMFHAIRJC-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 102100033350 ATP-dependent translocase ABCB1 Human genes 0.000 abstract 1
- 102000004328 Cytochrome P-450 CYP3A Human genes 0.000 abstract 1
- 108010081668 Cytochrome P-450 CYP3A Proteins 0.000 abstract 1
- 102000002004 Cytochrome P-450 Enzyme System Human genes 0.000 abstract 1
- 108010015742 Cytochrome P-450 Enzyme System Proteins 0.000 abstract 1
- 108010047230 Member 1 Subfamily B ATP Binding Cassette Transporter Proteins 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 230000036457 multidrug resistance Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/06—Peri-condensed systems
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202063088788P | 2020-10-07 | 2020-10-07 | |
PCT/US2021/053937 WO2022076663A1 (en) | 2020-10-07 | 2021-10-07 | Acetamido-phenyltetrazole derivatives and methods of using the same |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2023003933A true MX2023003933A (es) | 2023-07-05 |
Family
ID=78483546
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2023003933A MX2023003933A (es) | 2020-10-07 | 2021-10-07 | Derivados de acetamido-feniltetrazol y métodos para utilizar los mismos. |
Country Status (11)
Country | Link |
---|---|
US (1) | US11739089B2 (ko) |
EP (1) | EP4225747A1 (ko) |
JP (1) | JP2023544615A (ko) |
KR (1) | KR20230104151A (ko) |
CN (1) | CN116964044A (ko) |
AU (1) | AU2021358074A1 (ko) |
CA (1) | CA3194694A1 (ko) |
IL (1) | IL301516A (ko) |
MX (1) | MX2023003933A (ko) |
TW (1) | TW202233593A (ko) |
WO (1) | WO2022076663A1 (ko) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10118890B2 (en) | 2014-10-10 | 2018-11-06 | The Research Foundation For The State University Of New York | Trifluoromethoxylation of arenes via intramolecular trifluoromethoxy group migration |
CN110312130B (zh) * | 2019-06-25 | 2021-10-15 | 浙江大华技术股份有限公司 | 基于三角模式的帧间预测、视频编码方法及设备 |
TW202233593A (zh) | 2020-10-07 | 2022-09-01 | 美商亞瑟尼克斯公司 | 乙醯胺基-苯基四唑衍生物及其使用方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
AU4567193A (en) | 1992-07-10 | 1994-01-31 | Laboratoires Glaxo S.A. | Anilide derivatives |
US5763263A (en) | 1995-11-27 | 1998-06-09 | Dehlinger; Peter J. | Method and apparatus for producing position addressable combinatorial libraries |
GB9717576D0 (en) | 1997-08-19 | 1997-10-22 | Xenova Ltd | Pharmaceutical compounds |
KR100557093B1 (ko) | 2003-10-07 | 2006-03-03 | 한미약품 주식회사 | 다약제 내성 저해 활성을 갖는 테트라졸 유도체 및 그의제조방법 |
KR101466245B1 (ko) | 2010-01-15 | 2014-12-01 | 한미사이언스 주식회사 | 테트라졸 메탄설폰산 염의 제조방법 및 이에 사용되는 신규 화합물 |
KR101986683B1 (ko) | 2012-12-13 | 2019-06-10 | 한미약품 주식회사 | 테트라졸 유도체를 활성 성분으로 포함하는 용해도가 개선된 고체 분산체 |
WO2015152433A1 (en) | 2014-03-31 | 2015-10-08 | Hanmi Pharm. Co., Ltd. | Amorphous solid dispersion comprising paclitaxel, tablet comprising the same, and method for preparing the same |
KR102293907B1 (ko) | 2015-06-30 | 2021-08-26 | 한미약품 주식회사 | 이리노테칸 함유 경구용 고형제제 및 그 제조방법 |
TWI715636B (zh) | 2015-09-30 | 2021-01-11 | 香港商慧源香港創新有限公司 | 口服紫杉烷組合物及方法 |
WO2019071092A1 (en) | 2017-10-06 | 2019-04-11 | Athenex HK Innovative Limited | ORAL TAXANE COMPOSITIONS OF HIGH POWER AND METHODS |
TW202233593A (zh) | 2020-10-07 | 2022-09-01 | 美商亞瑟尼克斯公司 | 乙醯胺基-苯基四唑衍生物及其使用方法 |
-
2021
- 2021-10-07 TW TW110137339A patent/TW202233593A/zh unknown
- 2021-10-07 CA CA3194694A patent/CA3194694A1/en active Pending
- 2021-10-07 IL IL301516A patent/IL301516A/en unknown
- 2021-10-07 CN CN202180079852.2A patent/CN116964044A/zh active Pending
- 2021-10-07 US US17/495,935 patent/US11739089B2/en active Active
- 2021-10-07 WO PCT/US2021/053937 patent/WO2022076663A1/en active Application Filing
- 2021-10-07 MX MX2023003933A patent/MX2023003933A/es unknown
- 2021-10-07 KR KR1020237015140A patent/KR20230104151A/ko unknown
- 2021-10-07 EP EP21801761.4A patent/EP4225747A1/en active Pending
- 2021-10-07 AU AU2021358074A patent/AU2021358074A1/en active Pending
- 2021-10-07 JP JP2023521299A patent/JP2023544615A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
AU2021358074A1 (en) | 2023-04-27 |
EP4225747A1 (en) | 2023-08-16 |
KR20230104151A (ko) | 2023-07-07 |
US11739089B2 (en) | 2023-08-29 |
IL301516A (en) | 2023-05-01 |
US20220106312A1 (en) | 2022-04-07 |
CN116964044A (zh) | 2023-10-27 |
JP2023544615A (ja) | 2023-10-24 |
TW202233593A (zh) | 2022-09-01 |
WO2022076663A1 (en) | 2022-04-14 |
CA3194694A1 (en) | 2022-04-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2023003933A (es) | Derivados de acetamido-feniltetrazol y métodos para utilizar los mismos. | |
CR20200532A (es) | Compuestos de heteroarilo tetracíclicos | |
JOP20210241A1 (ar) | مركبات مدمجة ثلاثية الحلقة مفيدة كعوامل مضادة للسرطان | |
MX2022012306A (es) | Inhibidores alostericos de cromenona del fosfoinositido 3-quinasa (pi3k) para el tratamiento de enfermedades. | |
EA201000830A1 (ru) | Производные пиримидина для лечения астмы, хобл, аллергического ринита, аллергического конъюнктивита, атопического дерматита, рака, гепатита в, гепатита с, вич, впч, бактериальных инфекций и дерматоза | |
TW200621762A (en) | Novel compounds | |
JOP20210317A1 (ar) | مثبطات غير متجانسة ثنائية الحلقة لـ mat2a وطرق استخدامها لعلاج السرطان | |
EA200601350A1 (ru) | Азотсодержащие гетероциклические производные и их фармацевтические применения | |
EA200700099A1 (ru) | Производные пиридина | |
MX2009003874A (es) | Derivados de espiro-oxindol triciclicos y sus usos como agentes terapeuticos. | |
MEP23808A (en) | Pyridine[3,4-b]pyrazinones | |
EA200970913A1 (ru) | 2-пиридинкарбоксамидные производные в качестве модуляторов натриевых каналов | |
MX2010013682A (es) | Derivados de 2,4-diamino-l,3,5-triazina triciclicos utiles para el tratamiento del cancer y trastornos mieloproliferativos. | |
MX2021011118A (es) | Derivados de azolopiridina macrocíclicos como moduladores de eed y prc2. | |
NO20080670L (no) | Substituerte piperaziner som metabotrofiske glutamatreseptorantagonister | |
TW200637817A (en) | 5-aminoindole derivatives | |
MX2022009043A (es) | Compuestos de sulfonimidamida como moduladores de nlrp3. | |
MX2007007027A (es) | Derivados piperazinilpiridina como agentes anti-obesidad. | |
MX2023003927A (es) | Derivados de acetamido-fenilbenzamida y métodos para utilizar los mismos. | |
CR20210664A (es) | Inhibidores de la replicación del virus de inmunodeficiencia humana | |
MX2012007217A (es) | Derivados de (metilsulfonil) etilbenceno isoindolina y sus usos terapeuticos. | |
CR20220160A (es) | Derivados de piridazin-3(2h)-ona fusionados con azol | |
MX2021013135A (es) | Derivados de 1,1-dioxido de 3-amino-4h-benzo[e][1,2,4] tiadiazina como inhibidores de mrgx2. | |
MX2021015942A (es) | Composiciones y métodos para tratar trastornos del snc. | |
MX2021003508A (es) | Derivados de 5-azaindazol como antagonistas del receptor de adenosina. |